Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review

JE Megías-Vericat, D Martinez-Cuadron… - Expert Review of …, 2019 - Taylor & Francis
Introduction Induction chemotherapy based on anthracyclines and cytarabine (Ara-C)
combination remains the standard of care for acute myeloid leukemia (AML) patients who …
被引用次数：21 相关文章

Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review.

JE Megías-Vericat, D Martínez-Cuadrón… - Expert Review of …, 2019 - europepmc.org
Induction chemotherapy based on anthracyclines and cytarabine (Ara-C) combination
remains the standard of care for acute myeloid leukemia (AML) patients who are considered …

Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review

JE Megías-Vericat… - Expert review of …, 2019 - pubmed.ncbi.nlm.nih.gov
Induction chemotherapy based on anthracyclines and cytarabine (Ara-C) combination
remains the standard of care for acute myeloid leukemia (AML) patients who are considered …